Eton Pharmaceuticals, Inc. ETON Return on equity

Return on equity at other companies

HRO

HarrowHROW

-50%+17.5pp

XER

Xeris Biopharma Holdings, Inc.XERS

-209.8%—

ANI PharmaceuticalsANIP

21%+19.1pp

Zevra Therapeutics, Inc.ZVRA

34.8%+31.3pp

Ultragenyx PharmaceuticalRARE

-325.6%+36.9pp

Rigel PharmaceuticalsRIGL

174.1%—

FAQ

What is Eton Pharmaceuticals, Inc.'s return on equity?

Eton Pharmaceuticals, Inc. (ETON) reported return on equity of -34.2% in Q3 2025.

How has Eton Pharmaceuticals, Inc.'s return on equity changed year-over-year?

Eton Pharmaceuticals, Inc.'s return on equity decreased by 2.5% year-over-year, from -33.3% to -34.2%.

What is the long-term trend for Eton Pharmaceuticals, Inc.'s return on equity?

Over 2 years (2020 to 2024), Eton Pharmaceuticals, Inc.'s return on equity has grown at a -68.9% compound annual growth rate (CAGR), from -198.5% to -19.2%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.